We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 160

A ho-hum EEOC strategic plan? Maybe that's not so bad.
  • Constangy Brooks Smith & Prophete LLP
  • USA
  • February 16 2018

Not a lot to the EEOC's 2018-22 Strategic Enforcement Plan, but that might be good for employers. The Equal Employment Opportunity Commission recently

Keep Identifying Information out of Job Applications and Advertisements
  • Foley & Lardner LLP
  • USA
  • September 18 2017

Certain job advertisements have drawn media scrutiny in recent weeks, including dozens of postings seeking applicants with a “neutral” accent for

FTC Announces Settlement with Operators of Tech Support Scam
  • Buckley Sandler LLP
  • USA
  • June 14 2017

On June 7, the FTC announced two settlements in a pending action brought against defendants who allegedly used pop-up internet ads to deceive

Technology’s Impact on the Economy and Jobs
  • Conduent
  • USA
  • June 1 2017

The U.S. tech industry continues to grow with 6.9 million workers employed and 182,220 new jobs added in 2016. More than 25 million U.S. workers can

China’s Cyber Security Law - More Stringent Regulations for Network Security
  • CMS
  • China
  • November 8 2016

On 7 November 2016 the Standing Committee of the National People's Congress of the PRC has approved the third draft of the PRC Cyber Security Law

FTC Targets Pop-Up Ad Tech Scam
  • Manatt Phelps & Phillips LLP
  • USA
  • October 27 2016

The Federal Trade Commission hit Global Access Technical Support (and related individuals and entities) with an action accusing the defendants of

Consumer Protection in Retail: Weekly Roundup
  • Hunton Andrews Kurth LLP
  • USA
  • October 18 2016

On October 7, 2016, Mylan Inc. announced that it had agreed to pay $465 million to resolve a DOJ investigation into Mylan’s classification of EpiPen